ES2155802A1 - Activating antitumour polysaccharide drugs - Google Patents

Activating antitumour polysaccharide drugs

Info

Publication number
ES2155802A1
ES2155802A1 ES009902062A ES9902062A ES2155802A1 ES 2155802 A1 ES2155802 A1 ES 2155802A1 ES 009902062 A ES009902062 A ES 009902062A ES 9902062 A ES9902062 A ES 9902062A ES 2155802 A1 ES2155802 A1 ES 2155802A1
Authority
ES
Spain
Prior art keywords
antitumour
activating
polysaccharide
polysaccharide drugs
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009902062A
Other languages
Spanish (es)
Other versions
ES2155802B1 (en
Inventor
Kozo Niwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of ES2155802A1 publication Critical patent/ES2155802A1/en
Application granted granted Critical
Publication of ES2155802B1 publication Critical patent/ES2155802B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method for strengthening an antitumor activity by roasting a polysaccharide or mushroom containing b -glucan by far infrared rays, then, fermenting by adding "Koji", and further making an oily agent. Also claimed is a method of evaluating the efficacy of the drug by an in vitro method based on lipid peroxidation.
ES009902062A 1998-09-17 1999-09-16 PROCEDURE FOR REINFORCING AND EVALUATING THE EFFECTIVENESS OF THE ANTITUMOR ACTIOVITY OF PHARMACOS IN GROSS. Expired - Lifetime ES2155802B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (en) 1998-09-17 1998-11-13 Crude drug antitumor activity enhancing method, antitumor activity enhancing crude drug-containing composition, antitumor efficacy evaluating method of crude drug treatment, and antitumor efficacy evaluating method of crude drug

Publications (2)

Publication Number Publication Date
ES2155802A1 true ES2155802A1 (en) 2001-05-16
ES2155802B1 ES2155802B1 (en) 2001-12-01

Family

ID=26546176

Family Applications (1)

Application Number Title Priority Date Filing Date
ES009902062A Expired - Lifetime ES2155802B1 (en) 1998-09-17 1999-09-16 PROCEDURE FOR REINFORCING AND EVALUATING THE EFFECTIVENESS OF THE ANTITUMOR ACTIOVITY OF PHARMACOS IN GROSS.

Country Status (19)

Country Link
JP (1) JP2000159682A (en)
KR (1) KR20000023206A (en)
CN (1) CN1255376A (en)
AU (1) AU4486299A (en)
BE (1) BE1012725A5 (en)
CA (1) CA2282234A1 (en)
DE (1) DE19944695A1 (en)
DK (1) DK199901235A (en)
ES (1) ES2155802B1 (en)
FR (2) FR2783426A1 (en)
GB (2) GB9920710D0 (en)
ID (1) ID23150A (en)
IL (1) IL131722A0 (en)
IS (1) IS5183A (en)
IT (1) IT1307267B1 (en)
NL (2) NL1013049C2 (en)
NO (1) NO994463L (en)
SE (2) SE9903307L (en)
SG (1) SG76631A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040039195A (en) * 2001-04-27 2004-05-10 아지노모토 가부시키가이샤 Immunopotentiators
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (en) * 2001-05-21 2010-07-14 コンビ株式会社 Composition for controlling pathogen infection
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk ANTIDIABETIC TREATMENT
JP4826696B2 (en) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 Angiogenesis inhibitors
JP4681801B2 (en) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 Angiogenesis inhibitor and method for producing the same
KR100971599B1 (en) 2002-05-15 2010-07-20 비에이취엔 가부시끼가이샤 Compositions for the Prevention or Treatment of Vascular Associated Diseases
JP2005089417A (en) * 2003-09-19 2005-04-07 Noevir Co Ltd Composition for prevention/treatment of diabetes
JP4587441B2 (en) * 2004-02-12 2010-11-24 株式会社クレハ Novel diabetes treatment and food
KR20070041786A (en) 2004-09-17 2007-04-19 카부시키카이샤 에스·에스·아이 Agaricus Extract Inhibits Breast Cancer
JP2006273835A (en) * 2005-03-04 2006-10-12 Michishi Tani Malignant tumor therapeutic agent and food and drink containing the same
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
JPWO2011081024A1 (en) * 2009-12-29 2013-05-09 株式会社富士見養蜂園 Umami food and production method thereof
CN106333969A (en) * 2016-08-30 2017-01-18 青海民族大学 Agaricus gennadii HDAC1 enzyme inhibition effective part and preparation method and application
CN106309511A (en) * 2016-08-30 2017-01-11 青海民族大学 Effective part of agaricus gennadii for inhibiting CDC25 enzyme as well as preparation method and application of effective part
WO2019104579A1 (en) * 2017-11-30 2019-06-06 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (en) * 2020-12-16 2024-03-12 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Grifola frondosa
KR102602787B1 (en) * 2020-12-16 2023-11-17 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Sparassis crispa
KR102584680B1 (en) * 2020-12-17 2023-10-06 대한민국 Method for manufacturing tea of Lentinula edodes tea improved physiological activities and nutrition components

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (en) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field
ES2036496A1 (en) * 1991-08-14 1993-05-16 Kozo Niwa Low molecular weight vegetable composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (en) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd Food having antitumor function and production thereof
JP2955126B2 (en) * 1992-06-22 1999-10-04 笑代 丹羽 Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (en) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field
ES2036496A1 (en) * 1991-08-14 1993-05-16 Kozo Niwa Low molecular weight vegetable composition

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KAWAZOE, T. et al.: "Efficient transformation of ergosterol to vitamin D-2 by ultraviolet light irradiation", J. Japan. Soc. Food Sci. Technol., Vol. 42, no 4, paginas 262-267, (1995), ISSN 0029-0394, (resumen), BIOSIS [en linea]. Philadelphia, PA (EE.UU.): BIOSIS, [recuperado el 10.04.2001]. Recuperado de: EPOQUE, E.P.O. (Holanda) No de acceso: PREV199598311933 *
NIWA K. et al.: "Anti-cancer effect in vitro and clinical efficacy of a cancer therapeutic containing natural herbs (BG-104), exposed to far infrared-ray heating and fermentation process using Aspergillus oryzae", Oyo Yakuri, Vol. 47, no 5, paginas 465-77, (1994), ISSN: 0300-8533, (resumen), HCAPLUS [en linea]. Columbus, OH (EE.UU.): Chemical Abstracts Service [recuperado el 10.04.2001]. Recuperado de: STN International, Columbus, OH (EE.UU.). No de acceso 1994:49737 *
NIWA K. et al.: "Tapering effects on glucocorticoids in autoimmune diseases by natural antioxidant and anti-cancer drug treated with infrared ray heating, fermentation and lipophilization", Oyo Yakuri, Vol. 54, no 4, paginas 227-233, (1997), ISSN: 0300-8533, (resumen), HCAPLUS [en linea]. Columbus, OH (EE.UU.): Chemical Abstracts Service [recuperado el 10.04.2001]. Recuperado de: STN International, Columbus, OH (EE.UU.). No de acceso 1997:774347 *

Also Published As

Publication number Publication date
GB2341800A (en) 2000-03-29
GB9920710D0 (en) 1999-11-03
IT1307267B1 (en) 2001-10-30
CA2282234A1 (en) 2000-03-17
SE0100195L (en) 2001-01-24
SE9903307D0 (en) 1999-09-16
IL131722A0 (en) 2001-03-19
SE0100195D0 (en) 2001-01-24
NL1013049A1 (en) 2000-03-21
FR2788697A1 (en) 2000-07-28
JP2000159682A (en) 2000-06-13
GB9921387D0 (en) 1999-11-10
ITTO990784A0 (en) 1999-09-14
NL1019705A1 (en) 2002-01-29
NL1019705C2 (en) 2002-03-26
KR20000023206A (en) 2000-04-25
SG76631A1 (en) 2000-11-21
DE19944695A1 (en) 2000-03-30
FR2783426A1 (en) 2000-03-24
DK199901235A (en) 2000-03-18
ES2155802B1 (en) 2001-12-01
SE9903307L (en) 2000-03-18
NO994463L (en) 2000-03-20
AU4486299A (en) 2000-03-30
NO994463D0 (en) 1999-09-15
BE1012725A5 (en) 2001-02-06
ID23150A (en) 2000-03-23
CN1255376A (en) 2000-06-07
NL1013049C2 (en) 2002-01-11
IS5183A (en) 2000-03-17
ITTO990784A1 (en) 2001-03-14

Similar Documents

Publication Publication Date Title
SE0100195L (en) Evaluation procedures for anti-tumor activity
PL334337A1 (en) Derivatives of sulphonamides, method of obtaining them and their application as drugs
FR2794744B1 (en) METAL COMPLEXES OF BICYCLIC POLYAMINOACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN MEDICAL IMAGING
NO954996D0 (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
AU4133096A (en) Taxoid derivatives, their preparation and their use as antitumor agents
AU1917095A (en) 6-substituted mycophenolic and derivatives with immunosuppressive activity
AU1916995A (en) 4-amino derivatives of mycophenolic acid with immunosuppressant activity
PL321003A1 (en) Derivatives of piperasine, drugs containing them, their application and methods of obtaining them
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
FR2786769B1 (en) 2,5-DIAZABICYCLO [2.2.1] HEPTANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PL338143A1 (en) Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them
ES2055193T3 (en) NEW EPIMERAL OF 1 ALPHA-HYDROXY-VITAMIN D2 AND DERIVATIVES.
WO1999011252A3 (en) N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
PL341619A1 (en) Derivatives of cyclobutane, method of obtaining them and their therapeutic application
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
WO1997026867A3 (en) Solid instant-release forms of administration and process for producing the same
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
AU2002359918A1 (en) Blood bag system and method of inactivating pathogenic microorganisms
EP0971725A4 (en) Methods for treatment of scar tissue
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them
EP0919973A3 (en) Double technology combined alarm system with a contained and controlled consumption
AU7344994A (en) Liponucleotides of desoxynucleosides, their preaparation and their use as anti-viral drugs
AU3294700A (en) Self-contained and mobile washstand for recurrent use in medical environment
PL326844A1 (en) Novel derivatives of quinosalinodione, their production and implementation in drugs
Gandy Advertising baldly to the public

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20010516

Kind code of ref document: A1

Effective date: 20010516